Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there. Did your doctor somehow miss the recovery protocol that Pedro Bach-y-Rita used to recover fully back in 1958 with only a partial brain?

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, October 26, 2026

Gut microbiota-derived tryptophan metabolites and inflammatory factors enhance prediction of early neurological deterioration after intravenous thrombolysis in stroke patients: a comparative model study

 

Describing a problem with NO solution is a fireable offense in any business!

Gut microbiota-derived tryptophan metabolites and inflammatory factors enhance prediction of early neurological deterioration after intravenous thrombolysis in stroke patients: a comparative model study


  • W

    Wei Li 1†

  • Z

    Zhiyan Feng 2†

  • C

    Chunrong Zeng 2

  • Z

    Zhimei Cao 2

  • Y

    Yunfei Bai 2

  • H

    Honglei Wang 2

  • Jiagui Huang

    Jiagui Huang 2*

  • 1. Medical Imaging Center, Second People's Hospital of Yibin City-West China Yibin Hospital, Sichuan University, Yibin, China

  • 2. Department of Neurology, Second People’s Hospital of Yibin City-West China Yibin Hospital, Sichuan University, Yibin, China

Abstract


Background and purpose: 


Early neurological deterioration (END) after stroke thrombolysis predicts poor outcomes. This study developed predictive nomograms that incorporate gut-derived tryptophan metabolites and inflammatory markers to predict END.


Methods: 


We evaluated demographic, clinical, and laboratory variables, including gut-derived tryptophan metabolites and inflammatory markers. A multivariable logistic regression model was developed to predict END and presented as a nomogram. Model performance was assessed using variance inflation factors, ROC analysis, calibration curves, and decision curve analysis. Net Reclassification Improvement and Integrated Discrimination Improvement were used to compare models.


Results: 


In this study, END occurred in 11.26% of stroke patients and was independently associated with systolic blood pressure (SBP), fasting blood glucose, and serum levels of indole-3-propionic acid (IPA), indole-3-lactic acid (ILA), and interferon γ (IFN γ). Two nomogram models were developed to predict END: one based on conventional risk factors (SBP and glucose) and another incorporating emerging biomarkers (SBP, glucose, ILA, IPA, and IFN γ). The models achieved AUC scores of 0.719 (95% CI 0.658–0.780) and 0.909 (95% CI 0.879–0.939), respectively. Comparing the models showed a categorical Net Reclassification Improvement of 0.601 (p = 0.000) and an Integrated Discrimination Improvement of 0.197 (p = 0.000).


Conclusion: 


Incorporating gut microbiota-derived tryptophan metabolites and inflammatory factors improves prediction of END among thrombolyzed stroke patients.

No comments:

Post a Comment